ID1 and neoplasm: These results indicate that lack of Id1 in both tumor cells and tumor microenvironment, along with the blockade of the PD-1/PD-L1 axis favors the infiltration of different immune cell populations into the tumor, specifically the presence of CD8+ T lymphocytes, which may justify the antitumor activity associated with the double blockade.